Industry Focus Areas, Medical, Regulations
October 14, 2019
Via: Industry WeekJohnson & Johnson has taken some costly beatings in court this year. And it could get worse. Just last week, a jury ordered J&J to pay $8 billion for wrongfully pushing doctors to prescribe the anti-psychotic drug Risperdal. While the […]
September 26, 2023
September 21, 2023
September 19, 2023
September 14, 2023
September 12, 2023
August 29, 2023
September 19, 2023
September 21, 2023
September 12, 2023
September 7, 2023